Delivery Order SPE2DB22D3004-SPE2DB25FRA83
Award Date
6/11/25
Potential Completion Date
6/12/25
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency has awarded a firm fixed price delivery order for $5,852.26 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply Vraylar 4.5 mg capsules. The award is not set aside and is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that AmerisourceBergen Drug Corp holds with the Defense Logistics Agency to provide a comprehensive range of pharmaceutical products and medical supplies to support...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $2,212.01, is for the supply of 4.5 mg Vraylar capsules. This delivery order is part of a larger Indefinite Delivery Contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a $16,318.05 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract is to supply the DLA with Vraylar 3 mg capsules, a medication used for the treatment of mental health conditions. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $18,232.60, is for the delivery of Vraylar 1.5 mg capsules. The contract has an ultimate completion date of April 2, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Vraylar 1.5 mg capsules. The award has a ceiling value of $9,746.14 and is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This IDC provides comprehensive global pharmaceutical support to military healthcare programs...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,380.90, is for the delivery of Vraylar 4.5 mg capsules. It is a Firm Fixed Price delivery order contract with an ultimate completion date of October 31, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Vraylar 3 mg capsules. The contract, valued at $13,582.53, has a firm fixed price and runs through June 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive...
The U.S. Defense Logistics Agency (DLA) awarded a $67,237.41 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor, for the supply of 4,565,891,746 units of the medication Vraylar 3 mg capsules. This contract has an ultimate completion date of September 23, 2024. Amerisourcebergen has been awarded multiple indefinite delivery contracts (IDCs) by DLA Troop Support Medical and the Department of Justice Federal Bureau...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,748.66 firm-fixed-price delivery order is for the supply of Vraylar 6 mg capsules, a medication used to treat mental health conditions. The contract has an ultimate completion date of November 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract valued at $36,817.54 to AmerisourceBergen Drug Corp for the supply of VRAYLAR 1.5 MG CAPSULE 30S. This order was placed under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 through December 2025. AmerisourceBergen, a major pharmaceutical distributor, is providing these critical medical commodities to support military treatment...